ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Diffusion-Based Generative Model With Scaffold-Hopping Strategy Yields Highly Potent Bioactive Molecules.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
As a critical step in drug discovery, lead optimization is a profoundly complex endeavor with a notoriously high failure rate, as it necessitates the simultaneous optimization of multiple, often conflicting parameters, including physicochemical properties, drug-likeness, synthetic accessibility, and target binding affinity. While several generative models have been proposed for lead optimization under multi-property constraints, they still struggle to balance multi-objective optimization with sufficient scaffold-level exploration. To address this challenge, we present SMarT-Diff (Scaffold-based Multi-property Tuning Diffusion), a generative diffusion model that achieves this balance by reinventing scaffold hopping-enabling both property optimization and structural novelty. SMarT-Diff achieved superior performance across diverse molecular generation and optimization metrics. Notably, across both single-target (LRRK2, HPK1, GLP-1R) and dual-target (GSK3β/JNK3) molecular optimization tasks, the model consistently generated drug-like molecules exhibiting enhanced structural diversity, preserved pharmacophoric features, and high synthetic accessibility. Furthermore, wet-lab validation of our model-generated compounds against LRRK2 identified a highly promising candidate with an IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.